Last reviewed · How we verify
IntelliCap
At a glance
| Generic name | IntelliCap |
|---|---|
| Also known as | IntelliCap and metoprolol |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of the Microbial Composition in Lean and Obese Subjects
- Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN) (NA)
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males (PHASE1)
- MICRO-study: The IntelliCap® System as a Gastrointestinal Fluid Sampling Tool (NA)
- Explore the Performance of IntelliCap. (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IntelliCap CI brief — competitive landscape report
- IntelliCap updates RSS · CI watch RSS
- AstraZeneca portfolio CI